Ravikirti, “Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India”, J Pharm Pharm Sci, vol. 24, no. 3, pp. 343–350, Jul. 2021.